Follow
Manoj Rathinaswamy
Manoj Rathinaswamy
Calico Life Sciences
Verified email at calicolabs.com
Title
Cited by
Cited by
Year
Accurate prediction of protein structures and interactions using a three-track neural network
M Baek, F DiMaio, I Anishchenko, J Dauparas, S Ovchinnikov, GR Lee, ...
Science 373 (6557), 871-876, 2021
33502021
Ras binder induces a modified switch-II pocket in GTP and GDP states
DR Gentile, MK Rathinaswamy, ML Jenkins, SM Moss, BD Siempelkamp, ...
Cell chemical biology 24 (12), 1455-1466. e14, 2017
922017
Conformational sampling of membranes by Akt controls its activation and inactivation
I Lučić, MK Rathinaswamy, L Truebestein, DJ Hamelin, JE Burke, ...
Proceedings of the National Academy of Sciences 115 (17), E3940-E3949, 2018
832018
Class I phosphoinositide 3-kinase (PI3K) regulatory subunits and their roles in signaling and disease
MK Rathinaswamy, JE Burke
Advances in Biological Regulation 75, 100657, 2020
742020
Molecular mechanism of activation of class IA phosphoinositide 3-kinases (PI3Ks) by membrane-localized HRas
BD Siempelkamp, MK Rathinaswamy, ML Jenkins, JE Burke
Journal of Biological Chemistry 292 (29), 12256-12266, 2017
682017
Structure of the phosphoinositide 3-kinase (PI3K) p110γ-p101 complex reveals molecular mechanism of GPCR activation
MK Rathinaswamy, U Dalwadi, KD Fleming, C Adams, JTB Stariha, ...
Science Advances 7 (35), eabj4282, 2021
252021
Disease related mutations in PI3Kγ disrupt regulatory C-terminal dynamics and reveal a path to selective inhibitors
MK Rathinaswamy, Z Gaieb, KD Fleming, C Borsari, NJ Harris, BJ Moeller, ...
Elife 10, e64691, 2021
252021
Neolymphostin A is a covalent phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitor that employs an unusual electrophilic vinylogous ester
G Castro-Falcón, GS Seiler, O Demir, MK Rathinaswamy, D Hamelin, ...
Journal of medicinal chemistry 61 (23), 10463-10472, 2018
212018
Defining how oncogenic and developmental mutations of PIK3R1 alter the regulation of class IA phosphoinositide 3-kinases
GL Dornan, JTB Stariha, MK Rathinaswamy, CJ Powell, MJ Boulanger, ...
Structure 28 (2), 145-156. e5, 2020
152020
Oncogenic mutations of PIK3CA lead to increased membrane recruitment driven by reorientation of the ABD, p85 and C-terminus
ML Jenkins, H Ranga-Prasad, MAH Parson, NJ Harris, MK Rathinaswamy, ...
Nature Communications 14 (1), 181, 2023
122023
HDX-MS-optimized approach to characterize nanobodies as tools for biochemical and structural studies of class IB phosphoinositide 3-kinases
MK Rathinaswamy, KD Fleming, U Dalwadi, E Pardon, NJ Harris, CK Yip, ...
Structure 29 (12), 1371-1381. e6, 2021
92021
Molecular basis for differential activation of p101 and p84 complexes of PI3Kγ by Ras and GPCRs
MK Rathinaswamy, ML Jenkins, BR Duewell, X Zhang, NJ Harris, ...
Cell Reports 42 (3), 2023
62023
Allosteric activation or inhibition of PI3Kγ mediated through conformational changes in the p110γ helical domain
NJ Harris, ML Jenkins, SE Nam, MK Rathinaswamy, MAH Parson, ...
Elife 12, RP88058, 2023
12023
Molecular basis for the regulation of phosphoinositide 3-kinase γ (PI3Kγ)
MK Rathinaswamy
2021
The system can't perform the operation now. Try again later.
Articles 1–14